Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.

AUTOR(ES)

Bax, D E

RESUMO

Sulphasalazine has been shown to be useful in the management of rheumatoid arthritis. However, its use may be complicated by a skin rash. Eight patients with a rash have undergone desensitisation, the aim of which was to achieve a daily dose of 2 g sulphasalazine. This was successful in five patients, partially successful in two, and failed in one patient. Desensitisation to sulphasalazine is a simple outpatient procedure, which subsequently allows the majority of patients developing a skin rash to continue treatment.

Documentos Relacionados

• Sulphasalazine in rheumatoid arthritis: desensitising the patient with a skin rash.
• Cystic fibrosis presenting as kwashiorkor with florid skin rash.
• Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
• Rheumatoid Arthritis: discussions in patient management
• Association between gold induced skin rash and remission in patients with rheumatoid arthritis.